Drug & Medical Device Litigation 2026

The 31st Annual Conference on Drug & Medical Device Litigation is a premier event scheduled for December 2–3, 2026, at the New York Marriott Marquis. Organized by the American Conference Institute (ACI), this conference brings together over 400 professionals, including pharmaceutical and medical device litigators, in-house counsel, private practice attorneys, and members of the judiciary. The event focuses on emerging litigation trends, evolving multi-district litigation (MDL) strategies, and high-stakes case developments shaping the year ahead.

Key topics covered include multi-district litigation strategies, products liability defense, and catastrophic liability defense challenges. The conference features a new pre-conference Catastrophic Liability Defense LAB, offering practical workshops and real-world case studies to strengthen defense strategies. Attendees can also earn Continuing Legal Education (CLE) and ethics credits, with accreditation sought in jurisdictions requested by registrants.

The event offers numerous networking opportunities, including a pre-conference welcome cocktail reception on December 1, networking breakfasts, luncheons, extended breaks, and a cocktail reception after Day One. Notable speakers include in-house leaders from companies such as Medtronic, Bristol-Myers Squibb, Novo Nordisk, Johnson & Johnson, and Gilead Sciences, as well as top defense attorneys and members of the judiciary.

This conference is ideal for pharmaceutical and medical device litigators, in-house counsel, private practice attorneys, and members of the judiciary seeking to stay ahead in an increasingly complex litigation landscape. Attendees will gain insights into emerging legal trends, regulatory changes, and strategies for effective litigation in these complex areas.